Efficacy of Voice Treatment for Parkinson's Disease
Parkinson's Disease, Dysphagia, Dysarthria
About this trial
This is an interventional treatment trial for Parkinson's Disease focused on measuring Parkinson's disease, Swallowing difficulties, speech, voice
Eligibility Criteria
Inclusion Criteria: Idiopathic Parkinson's Disease (IPD) None or mild dementia None, mild or moderate depression Mild, moderate or severe speech, voice, and swallowing disorder Exclusion Criteria: Severe depression Moderate or severe dementia Symptoms of another neurological condition other than or in addition to IPD or drug abuse Head or neck cancer Significant history of gastrointestinal disease or surgery Speech or voice disorders unrelated to IPD Neurosurgery, not for management of PD symptoms Laryngeal pathology/surgery Full-course Lee Silverman Voice Treatment (LSVT®) Smoked in last four years Absence of speech, voice or swallowing disorder Severe temporomandibular joint disorder Pregnancy (or the possibility of pregnancy) Hearing loss unexpected for his/her chronological age
Sites / Locations
- National Center for Voice and Speech-Denver; An Affiliate of the unniversity of Colorado
- University of Texas HSC San Antonio
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
No Intervention
No Intervention
Voice/Respiratory Treatment
Articulation Treatment
Subjects with PD in a no treatment group
Healthy Control Subjects
4 Days a week for 4 weeks with focus on high intensity voice exercises
4 days a week for 4 weeks with focus on high intensity articulation tasks
Subjects do not receive therapy during experimental phases, and will be offered therapy at the end of the study enrollment period.
Subjects are without Parkinson disease and will not receive therapy.